Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;61(Suppl 2):72-75.
doi: 10.1007/s00120-021-01664-9. Epub 2021 Oct 13.

[62/m-acute lumbago and prostate-specific antigen 1430 ng/ml : Preparation for the medical specialist examination: part 22]

[Article in German]
Miriam Hegemann  1
Affiliations

[62/m-acute lumbago and prostate-specific antigen 1430 ng/ml : Preparation for the medical specialist examination: part 22]

[Article in German]
Miriam Hegemann. Urologe A. 2022 Feb.
No abstract available

PubMed Disclaimer

References

Literatur

    1. Fizazi K, Tran N, Fein L et al (2019) Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial. Lancet Oncol 20:686–700. https://doi.org/10.1016/S1470-2045(19)30082-8 - DOI - PubMed
    1. Kumar RJ, Barqawi A, Crawford ED (2005) Adverse events associated with hormonal therapy for prostate cancer. Rev Urol 7:S37–S43 - PubMed - PMC
    1. Magee DE, Singal RK (2020) Androgen deprivation therapy: indications, methods of utilization, side effects and their management. Can J Urol 27:11–16 - PubMed
    1. Nguyen PL, Alibhai SMH, Basaria S et al (2015) Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 67:825–836. https://doi.org/10.1016/j.eururo.2014.07.010 - DOI - PubMed
    1. Sweeney CJ, Chen Y‑H, Carducci M et al (2015) Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med 373:737–746. https://doi.org/10.1056/NEJMoa1503747 - DOI - PubMed - PMC

Substances

LinkOut - more resources